| Literature DB >> 35573792 |
José Ignacio Manzano1, Ana Perea-Martínez1, Raquel García-Hernández1, Eduardo Andrés-León1, Laura C Terrón-Camero1, José Antonio Poveda2, Francisco Gamarro1.
Abstract
To increase our understanding of factors contributing to therapeutic failure (TF) in leishmaniasis, we have studied some plasma membrane features of host THP-1 cells infected with clinical isolates of Leishmania infantum from patients with leishmaniasis and TF. The fluorescent probes DPH and TMA-DPH were used to measure changes in membrane fluidity at various depths of the plasma membranes. Steady-state fluorescence anisotropy of DPH embedded in the infected THP-1 membranes showed a significant increase, thereby suggesting a substantial decrease in plasma membrane fluidity relative to controls. Considering that cholesterol affects membrane fluidity and permeability, we determined the cholesterol content in plasma membrane fractions of human macrophages infected with these L. infantum lines and observed a significant increase in cholesterol content that correlates with the measured decrease in plasma membrane fluidity. In order to define the pathways that could explain the increase in cholesterol content, we studied the transcriptomics of the cholesterol-enriched pathways in host THP-1 cells infected with TF clinical isolates by RNA-seq. Specifically, we focused on four enriched Gene Ontology (GO) terms namely cholesterol efflux, cholesterol transport, cholesterol metabolic process and cholesterol storage. Additionally, we analyzed the genes involved in these pathways. Overall, this study shows that these clinical isolates are able to modulate the expression of specific genes in host cells, thereby modifying the cholesterol content in plasma membranes and inducing changes in plasma membrane fluidity that could be associated with the parasite's ability to survive in the host macrophages, thereby possibly contributing to immune evasion and TF.Entities:
Keywords: Leishmania infantum; host cholesterol content; host-cell modulation; human macrophages; plasma membrane fluidity; transcriptomic analysis
Mesh:
Substances:
Year: 2022 PMID: 35573792 PMCID: PMC9106381 DOI: 10.3389/fcimb.2022.878711
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 6.073
Fluorescence anisotropy data for THP-1 cells.
| rDPH | rTMA-DPH | |
|---|---|---|
| Uninfected cells | 0.170 ± 0.008 | 0.251 ± 0.008 |
| Phagocytosis control | 0.159 ± 0.005 | 0.261 ± 0.008 |
| Hi-LJPC | 0.159 ± 0.004 | 0.271 ± 0.004 |
| Hi-L2070 | 0.179 ± 0.003 *Ψ | 0.271 ± 0.006 |
| Hi-L2165 | 0.190 ± 0.003 *Ψ | 0.266 ± 0.013 |
| Hi-L2255 | 0.208 ± 0.001 *Ψ | 0.273 ± 0.008 |
| Hi-L2221 | 0.179 ± 0.004 *Ψ | 0.268 ± 0.009 |
rDPH and rTMA-DPH indicate the steady-state fluorescence anisotropy values of the probes DPH and TMA-DPH incorporated in plasma membrane fractions of THP-1 cells. The assays were measured at 37°C and represent the mean ± standard deviation for at least three independent assays. Significant differences were determined using Student’s t-test (*p < 0.05 vs Phagocytosis control; Ψp < 0.05 vs Hi-LJPC).
Figure 1Cholesterol content in plasma membrane fractions of THP-1 cells infected with clinical TF L. infantum lines. The cholesterol content of the plasma membrane fractions isolated from THP-1 cells was measured using the Amplex Red Cholesterol kit, as described in the Materials and Methods section. The dashed line indicates the fluorescence value for the control. Values are the mean ± SD of three independent experiments. Significant differences versus the phagocytosis control were determined using Student’s t-test (*p < 0.05).
Figure 2Gene Ontology (GO) enrichment analysis of the cholesterol pathway in the biological process category. Enriched pathways of THP-1 cells infected with the different Leishmania lines are highlighted in yellow. Cell lines with enriched routes are indicated by colored boxes (blue, Hi-L2165; red, Hi-L2221; yellow, Hi-L2070; and green, Hi-L2255). The most relevant pathways for the study are framed with a red square. The color of arrows indicates the effect of pathways. Snapshot can be downloaded from ebi.ac.uk/QuickGO.
Figure 3Heatmaps of genes from four selected cholesterol GO biological processes. The heatmap depicts the expression profile of genes from THP-1 cells infected with L. infantum lines. Red represents upregulation and blue downregulation. (A) Log2FC values for genes of the enriched pathways cholesterol storage (GO:0010878) and cholesterol metabolic process (GO:0008203). (B) Log2FC values from genes of the enriched pathways cholesterol efflux (GO:0033344) and cholesterol transport (GO:0030301).
Most relevant DEGs of cholesterol routes in THP-1 cells after infection with L. infantum lines.
| Gene ID | Function | Lines | Log2FC | FDR-value |
|---|---|---|---|---|
|
| Cholesterol efflux across plasma membrane | Hi-L2165 | 0.693 | 6.678E-36 |
|
| Endocytosis of modified low density lipoproteins (LDLs) | Hi-L2165 | 1.348 | 3.822E-115 |
|
| Control the expression of genes important for cholesterol uptake, efflux, transport, and excretion in multiple tissues | Hi-L2165 | 1.104 | 7.752E-23 |
|
| Cholesterol homeostasis | Hi-L2165 | 0.764 | 3.743E-16 |
|
| Central role in high density lipoprotein (HDL) and very low density lipoprotein (VLDL) metabolism | Hi-L2165 | 0.751 | 3.200E-26 |
|
| Essential for the normal catabolism of triglyceride-rich lipoprotein constituents | Hi-L2165 | 0.872 | 3.738E-41 |
|
| Low-density lipoprotein receptor | Hi-L2165 | 0.972 | 2.457E-34 |
|
| Receptor for high density lipoprotein cholesterol (HDL) | Hi-L2165 | 0.608 | 1.191E-15 |
|
| Remove cholesterol from the endosomal/lysosomal compartment | Hi-L2165 | 0.694 | 6.679E-36 |
|
| Desaturase involved in the biosynthesis of cholesterol | Hi-L2165 | 1.187 | 6.920E-174 |
|
| Binding of long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport | Hi-L2165 | 1.069 | 1.074E-170 |
|
| Lipoprotein lipase involved in uptake | Hi-L2221 | 1.634 | 6.172E-26 |
|
| This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the signaling pathway | Hi-L2221 | -0.620 | 2.261E-17 |
|
| Cell surface receptor involved in endocytosis of specific ligands | Hi-L2221 | -0.748 | 1.567E-06 |
|
| Stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism | Hi-L2221 | -2.370 | 0.010 |
|
| Plays an important role in lipoprotein metabolism as an activator of lipoprotein lipase | Hi-L2221 | 0.630 | 1.409E-13 |
|
| Phospholipid efflux translocator | Hi-L2165 | 0.741 | 4.789E-05 |
Profile of DEGs for THP-1 cells after infection with different L. infantum lines, as described in the Materials and Methods section. The analysis was based on log2FC and false discovery rates (FDRs). Non-statistically significant values (log2FC) with similar trends are shown in italics.
Figure 4Schematic representation of general cholesterol pathways modulated in THP-1 host cells after infection with Leishmania lines from TF. Details of the processes that could be affected in the host cell after infection with TF Leishmania lines are indicated with a letter (A–E) and described in the Discussion section. Upregulated and downregulated genes are shown in red and blue, respectively. * For the ABCG1 transporter only. PM, plasma membrane.